New Maintenance Option Approved for Asthma: Breztri
FDA approves Breztri as first single-inhaler triple therapy for asthma in patients 12 and older, offering new maintenance option with reduced exacerbations.
Read insighttherapeutic areas
Pulmonology
Pulmonology is monitored by UniPharma because shifts in demand, reimbursement, regulation, competition, or supply priorities can reshape procurement and launch planning.